FASTENAL CO - 10-Q Summary (Q2 2025)
Business Context and Reporting Period
This filing covers the quarterly period ended June 30, 2025. Fastenal Company is a global leader in the wholesale distribution of industrial and construction supplies, operating through a network of over 1,500 branch locations. The company serves manufacturing, non-residential construction, and other end markets. All share and per-share data have been retroactively adjusted to reflect a two-for-one stock split effective May 21, 2025.
Key Financial Metrics
| Metric | Q2 2025 (3 Months) | Q2 2024 (3 Months) | YTD 2025 (6 Months) | YTD 2024 (6 Months) |
|---|---|---|---|---|
| Net Sales | $2,080.3M | $1,916.2M | $4,039.7M | $3,811.3M |
| Gross Profit | $942.8M (45.3%) | $863.5M (45.1%) | $1,826.7M (45.2%) | $1,725.1M (45.3%) |
| Operating Income | $436.1M (21.0%) | $386.9M (20.2%) | $830.0M (20.5%) | $777.1M (20.4%) |
| Net Income | $330.3M | $292.7M | $628.9M | $590.4M |
| Diluted EPS | $0.29 | $0.25 | $0.55 | $0.51 |
| Cash from Operations | $278.6M | $258.0M | $540.8M | $593.6M |
| Total Debt | $230.0M | $235.0M | $230.0M | $200.0M (Dec 2024) |
| Cash & Equivalents | $237.8M | $255.5M | $237.8M | $255.8M (Dec 2024) |
Material Changes vs. Prior Period
- Sales Growth: Q2 2025 net sales increased 8.6% year-over-year, driven by a 140-170 basis point positive impact from pricing actions and growth in unit sales. Daily sales rose 8.6% to $32.5M.
- Margin Expansion: Operating margin improved to 21.0% in Q2 2025 from 20.2% in Q2 2024, aided by favorable price/cost dynamics and SG&A leverage (SG&A grew 6.3% vs. sales growth of 8.6%).
- Product Mix: Non-fastener product lines (Safety, Electrical, Janitorial) outperformed fasteners. Safety supplies grew 10.7% in daily sales, while total fasteners grew 6.6%.
- Customer Dynamics: Contract sales grew 11.0% in daily sales, significantly outpacing non-contract sales which grew 2.6%. The number of customer sites spending $50K+ per month increased 12.4% year-over-year.
- Working Capital: Accounts receivable and inventories increased significantly (9.9% and 14.7% respectively over the last 12 months) to support sales growth and anticipated tariff impacts.
Guidance, Outlook, and Risks
- Capital Expenditures: Management expects 2025 net capital expenditures to range between $250.0M and $270.0M, a reduction from the original guidance of $265.0M-$285.0M. Spending is focused on distribution center replacements (Utah, Atlanta), IT projects, and FMI hardware.
- FMI Targets: The goal for weighted FASTBin and FASTVend device signings in 2025 is 25,000 to 26,000 MEU, revised down from a previous target of 28,000 to 30,000 MEU.
- Tax Legislation: The company is evaluating the impact of the "One Big Beautiful Bill Act" (H.R. 1) enacted July 4, 2025, which includes 100% bonus depreciation and full expensing of R&D. Management does not expect a material change to the ongoing tax rate (approx. 24.5%).
- Risks: Key risks include global economic volatility, geopolitical developments, and the impact of new and expanded tariffs on import costs and supply chains. Management notes that while tariff impacts were immaterial in the first half of 2025, exposure may increase as lower-tariff inventory is depleted.
- Dividends: A quarterly dividend of $0.22 per share was declared on July 11, 2025, payable August 26, 2025.
Investor Verification Checklist
- Tariff Impact Timing: Verify the timeline for inventory depletion and the specific cost pass-through mechanisms for new tariffs enacted in early 2025.
- Fastener Demand: Monitor the divergence between fastener growth (6.6% DSR) and non-fastener growth (9.5% DSR) to assess exposure to the sluggish manufacturing sector.
- Working Capital Efficiency: Track the ratio of inventory and receivables growth against sales growth to ensure the build-up is not becoming a drag on cash flow.
- Capital Allocation: Confirm the execution of the revised capital expenditure plan, particularly the completion of the Utah hub and start of the Atlanta hub.
- Contract vs. Non-Contract Mix: Assess the sustainability of the 11.0% growth in contract sales versus the 2.6% growth in non-contract sales as a leading indicator of market share gains.